• Fabulate

  Led · Equity · Aug 2026

  Fabulate is an influencer marketing and technology platform that has expanded from Australia into multiple APAC markets including New Zealand, Singapore, Malaysia, the Philippines, Vietnam, Thailand, Indonesia, South Korea and Japan. The company has developed an AI-powered product suite, including a product called SparQ, to support discovery, campaign execution and measurement at scale. Fabulate describes itself as profitable and has continued hiring regional commercial leads to support growth. Leadership cited the business's differentiated technology and disciplined execution as drivers of its expansion. The platform is used by brands to discover, vet, manage and measure creator marketing, and the recent funding is intended to accelerate growth across the region.

• Eleos Health

  Participated · Series C · Jan 2025

  Eleos builds AI agents and multimodal LLM-powered tools that streamline clinical documentation, surface care insights, and improve patient engagement for behavioral health providers. The company recently launched Eleos Compliance, a clinical documentation improvement (CDI) product that uses agentic AI to flag documentation errors and simplify appeals and accreditation work. Eleos uses the industry’s largest dataset of real-world treatment sessions and claims randomized controlled trial results showing >80% faster progress note submission, doubled client engagement, and 3–4x improved care outcomes versus treatment as usual. The company has more than 120 customer organizations across 30+ U.S. states and reports rapid revenue growth, tripling annual revenue over its first three years and doubling revenue in 2024. Eleos plans to use new funding to expand product offerings, grow its commercial team, hire senior leaders and engineering/data talent, and push into underserved segments—particularly substance use disorder and post-acute behavioral healthcare. Eleos Health develops AI that interprets, analyzes and documents behavioral health conversations using proprietary, behavioral health–specific large language models trained on treatment data and clinical expertise. The system reduces operational burden on providers by automating documentation and surfacing objective insights into evidence-based care and the therapeutic alliance. Leadership teams can scale supervision and training and gain visibility into staff activity, caseloads, performance and population health. The company plans new and enhanced AI solutions for group therapy, compliance automation, case management, concurrent documentation and value‑based care support. Eleos intends to expand its reach to more behavioral health providers and segments, deepen strategic partnerships with EHRs and industry associations, and hire more than 50 people by the end of 2024. It is led by CEO Alon Joffe and is based in Boston and Tel Aviv. Eleos Health provides CareOps Automation solutions that consolidate the behavioral care workflow by automating operational necessities, including documentation and compliance administration, and by delivering session intelligence. Its session intelligence tools generate clinical insights that enable clinicians, providers, and networks to track treatment and progress in a measurable way. The company is led by CEO Alon Joffe and is used by thousands of clinicians across more than 20 national care providers and health plans, including Gaudenzia Home, The Brookline Center for Mental Health, and Coleman Health Services. Eleos has captured more than 6.5 million minutes of treatment to date and is projecting 30 million minutes captured by the end of 2022. The company intends to use the funding to accelerate growth and expand its operations, team, and product. Eleos is based in Boston, MA. Eleos Health develops an AI-powered Speech-to-Insights system that analyzes behavioral health sessions to surface actionable insights for clinicians. Its VoiceAI technology runs securely in the background of sessions and analyzes hundreds of data parameters to accelerate clinical decision-making and personalize care. The company has deployed its solution with over a dozen provider organizations, including Solvista Health, Achieve, Yeshiva University and ReachLink. Eleos plans to use the recent funding to expand sales, marketing, and solution delivery teams needed to meet demand for enterprise software deployments across providers and payors. Founded in 2020 and based in Boston and Tel Aviv, the company has added Dr. David Shulkin to its board. Eleos closed a $6M seed round in 2021.

• SourseAI

  Led · Series A · Dec 2023

  SourseAI is a Sydney-based decision intelligence startup offering Atlas, a SaaS decision-augmentation platform that combines applied AI and industry-based models. The platform targets telcos and supports use cases such as product pricing, marketing spend optimization, churn management, and cross-sell/upsell offers. SourseAI plans to use the funds to expand its global presence beginning with Europe and to increase its European headcount. The company also intends to double the size of its Australian-based research and development team. SourseAI raised $3.0M in a Series A round in December 2023 led by Centerstone Capital. Company entity is listed as Sourse Pty Ltd and its website is https://www.sourse.ai/. SourseAI builds an augmented intelligence platform that applies industry-specific machine learning models to help executives make data-driven decisions and to deliver algorithmic recommendation and personalization for media companies. The company targets C-suite decision-making in media, telco and utilities and offers predictive feed capabilities similar to those used by YouTube, Facebook and Spotify. SourseAI says its recommender has previously driven more than sevenfold growth in monthly audience engagement and extended average watch time per user from eight minutes to over 45 minutes in an OTT implementation. The startup will use the newly raised funds to accelerate development and scale of its platform and broaden adoption across customer teams. The company emphasizes improving engagement metrics and advertising yield for partners through personalization and audience behavioural insights.

• 6clicks

  Led · Series A · Sep 2022

  6clicks provides an AI-powered GRC platform that helps organizations manage governance, risk and compliance frameworks, obligations, and processes. The product includes AI capabilities and advanced reporting and the company is developing a next-generation GRC Cyber platform. 6clicks plans to invest the new capital into technology, its worldwide partner ecosystem, content, and third-party apps. The company reports rapid growth—quadrupling in size over the prior year—with over 3,000 users and 80 partners. It has offices in the United States, Great Britain, India, and Australia and has recently expanded distribution through a deal with Synnex. Leadership changes include John Meacock joining the board to support engagement with global advisory firms. 6clicks offers a cloud-backed platform that automates the entire risk management lifecycle, including assessment, compliance, templates and libraries, a risk-monitoring app, and a regulatory news feed called 6clicks Pulse. The company was founded in 2019 by former KPMG leaders Anthony Stevens, Louis Strauss and Andrew Robinson. Its product is positioned to serve consulting firms and enterprise clients — current customers include BDO and King & Wood Mallesons. 6clicks has begun international expansion, with operations in India, Singapore, the UK and the US. The startup says it aims to be the "operating system for risk and compliance for businesses around the world." Financially, the firm has raised multiple rounds and now has over $7 million in capital to fuel growth. Management cites growing global regulatory complexity and post-pandemic digital risks as drivers of demand for its solution. 6clicks offers a cloud-based product to help businesses automate and manage risk assessment, risk management, cybersecurity and compliance operations. Its solutions are tailored to sector-specific regulations, the jurisdiction and companies' own policies. The company was founded by former KPMG partner and chief digital officer Anthony Stevens, former KPMG digital consultant Louis Strauss and TrustyGate founder Andrew Robinson, and launched into the market in November last year. Since launch it has expanded into India and Singapore, and the team is looking to move into the US market within months. Financially, 6clicks has secured $2.2 million in funding from a group of high-net-worth individuals. The startup is positioning itself as the "operating system" for business risk and compliance as it pursues global growth.

• WeAre8

  Participated · Series B · Mar 2022

  WeAre8 is a B Corp social platform that pays users and makes donations each time people watch ads. Its core product blends a hate-free social feed called the 8Stage with a self-serve ad manager that lets brands set up and manage campaigns. The company reports average click-through rates above 30% versus a 0.9% industry average, and shares 50% of advertiser spend with users, plus 5% to charities and 5% to a creator fund. Since its 2021 UK launch it has run campaigns for 20+ brands and secured commercial agreements, including a distribution/pre-installation deal with EE/BT and contracts with Cadbury, Heineken, Chip and Clim8, as well as partnerships with agencies Dentsu, GroupM and Publicis. Channel 4 and UKTV have collectively invested over $4M in airtime to support reach. The company says it plans to scale globally, starting with the US and Australia later this year, and the Crowdcube raise reflects a reported pre-money valuation of £35,981,146. WeAre8 is a ground-breaking app that aims to help people reclaim economic power and mobilise millions to drive real-world change. Its core product asks users to watch ads for about two minutes a day, valuing and paying them for their time while directing over 60% of ad spend to people and causes. Celebrities are contributing content and some serve as investors—named backers include Clare Balding and Rio Ferdinand—and other talent partners include Ugo Monye, AJ Pritchard and Harrison Osterfield. The company positions itself as a democratising alternative to traditional social platforms, putting people and the planet at the economic centre of the digital ad ecosystem. WeAre8 has launched a Crowdcube crowdfunding campaign to let the public invest alongside high-profile celebrity and institutional backers. It has also confirmed new Series B participation from UKTV Ventures, which committed $1.2 million in advertising airtime as media-for-equity. WeAre8 operates a hate-free social app that pays users to watch advertisements and offers an ad-buying platform for advertisers focused on ESG and sustainability outcomes. The platform shares 55% of every pound advertisers spend directly with people and charities, with an additional 5% allocated to a creator fund for micro shows and collaborations on the 8Stage. Led by founder and CEO Sue Fennessy, the company emphasizes a hate-free evolution of the social feed and content-driven engagement. WeAre8 has been operating in stealth with a team of 52 employees while developing its technology for a full global launch, now imminent in the UK. The company was certified as a B-Corporation in 2020. It plans to use the new funding to expand operations and marketing and to drive awareness via upcoming TV activity. Led by founder and chairman Sue Fennessy, 8 Enterprises operates a premium content sharing platform that lets creators own, control and profit from everything they upload. The service offers a customizable interface for sharing, monetizing, and allowing direct donations to causes. At launch the company announced a roster of over 250 influential content partners across television, music, film, sports, fashion and philanthropy. Named partners include Usher, Donna Karan, Jamie Oliver, Patricia Arquette and Keep A Child Alive/Alicia Keys. 8 is in closed beta on the web and mobile web, with a native iOS app scheduled for December 2014 and Android plus an ad marketplace planned for early 2015. Financially, the company completed a $4.2M seed funding round to support its launch and product rollouts.

No current team members are available.